Published in Diabetes on October 01, 1977
Regulation of lipolysis in severely burned children. Ann Surg (1987) 1.22
Palmitate and glycerol kinetics during brief starvation in normal weight young adult and elderly subjects. J Clin Invest (1986) 0.97
Effects of adrenaline on ketogenesis from long- and medium-chain fatty acids in starved rats. Biochem J (1982) 0.93
Beta-adrenergic blockade restores glucose's antiketogenic activity after exercise in carbohydrate-depleted athletes. J Physiol (1987) 0.79
Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc (1999) 3.05
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab (1986) 2.80
A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. JAMA (1998) 2.29
Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine. Ann Intern Med (1992) 2.11
Thyrotoxicosis presenting as choreoathetosis. Ann Intern Med (1970) 2.02
Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab (1980) 1.99
Meal composition is a determinant of lispro-induced hypoglycemia in IDDM. Diabetes Care (1997) 1.48
Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate. Fertil Steril (1997) 1.43
Insulin suppresses its own secretion in vivo. Diabetes (1987) 1.31
Detection of antibody to hepatitis-associated antigen in hemophilia patients and in voluntary blood donors. Vox Sang (1973) 1.29
Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J Clin Invest (1969) 1.22
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab (1993) 1.22
Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab (1983) 1.21
The regulation of plasma ketone body concentration by counter-regulatory hormones in man. III. Effects of norepinephrine in normal man. Diabetes (1979) 1.16
In search of the subcutaneous-insulin-resistance syndrome. N Engl J Med (1986) 1.16
Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem (1992) 1.14
Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review. Diabetes Obes Metab (1999) 1.09
Short-term fasting is a mechanism for the development of euglycemic ketoacidosis during periods of insulin deficiency. J Clin Endocrinol Metab (1993) 1.08
High density lipoprotein--key to anti-atherogenesis. J Chronic Dis (1978) 1.07
The etiology of incapacitating, brittle diabetes. Diabetes Care (1985) 1.04
Radioimmunoassay of beta lipoprotein-protein of rat serum. J Clin Invest (1969) 1.01
Successful treatment of severe refractory sulfonylurea-induced hypoglycemia with octreotide. Diabetes Care (1993) 0.98
Cardiovascular and metabolic effects of exercise: the strong case for conditioning. Postgrad Med (1978) 0.97
Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism (1979) 0.97
The kinetics of peritoneal insulin absorption. Metabolism (1981) 0.96
Hypolipemic action of glucagon in experimental endogenous lipemia in the rat. J Lipid Res (1973) 0.96
A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diabetes Care (2001) 0.95
Dynamics of insulin and glucagon secretions in severely burned patients. J Trauma (1977) 0.95
Multiple myeloma, cryoglobulinemia and xanthomatosis. Distinct clinical and biochemical syndromes in two patients. Am J Med (1975) 0.95
Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis. Metabolism (2001) 0.95
Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population. Diabetes Care (1998) 0.94
Glucagon secretion and activity in the cobalt chloride-treated rat. Am J Physiol (1973) 0.93
Dose response to insulin in man: differential effects on glucose and ketone body regulation. J Clin Endocrinol Metab (1977) 0.91
Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects. Diabetes (1975) 0.90
Pathogenesis of diabetic ketoacidosis: a reappraisal. Diabetes Care (1980) 0.90
Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations. Metabolism (1994) 0.90
Evaluation of a colorimetric method for determination of glycosylated hemoglobin. Clin Chem (1983) 0.89
"Normal" insulin secretion: the goal of artificial insulin delivery systems? Diabetes Care (1980) 0.89
Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man. Metabolism (1978) 0.89
Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study. J Clin Endocrinol Metab (1996) 0.88
Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. J Clin Endocrinol Metab (1998) 0.88
Underestimation of hepatic glucose production by radioactive and stable tracers. Am J Physiol (1987) 0.86
Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide. Am J Med (1977) 0.85
Optimal administration of lispro insulin in hyperglycemic type 1 diabetes. Diabetes Care (1999) 0.85
Five-day programmed intraperitoneal insulin delivery in insulin-dependent diabetic man. J Clin Endocrinol Metab (1981) 0.85
Effect of glucose feeding on lipoprotein synthesis in the rat. Am J Physiol (1969) 0.85
Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diabetologia (1980) 0.85
The role of glucagon in the regulation of plasma lipids. Metabolism (1979) 0.85
The peritoneum--a potential insulin delivery route for a mechanical pancreas. Diabetes Care (1980) 0.85
A remotely programmable insulin delivery system. Successful short-term implantation in man. JAMA (1982) 0.85
Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr (1993) 0.84
The temporal relationship between endogenously secreted stress hormones and metabolic decompensation in diabetic man. J Clin Endocrinol Metab (1980) 0.84
The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man. Horm Metab Res (1977) 0.84
Synthesis of plasma triglycerides in endogenous hypertriglyceridemia. J Lipid Res (1971) 0.84
Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data. J Lipid Res (1983) 0.84
The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system. Metabolism (1979) 0.84
Effect of clofibrate on arginine-induced insulin and glucagon secretion. Metabolism (1973) 0.83
Metabolic and clinical significance of ketosis. Spec Top Endocrinol Metab (1982) 0.83
Modified hospital pumps for pulsed insulin delivery. Med Prog Technol (1980) 0.83
Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man. Metabolism (1996) 0.82
Receptor depletion in diabetes mellitus: correction with therapy. Diabetes Care (1981) 0.82
Myocardial atrophy in acquired immunodeficiency syndrome--associated wasting. Am Heart J (1995) 0.82
The intravenous, intraperitoneal, and subcutaneous routes of insulin delivery in diabetic man. Diabetes (1979) 0.82
Glucagon and lipoproteins. Metabolism (1976) 0.81
The role of catecholamines in metabolic acidosis. Ciba Found Symp (1982) 0.81
Glucagon, insulin, and glucose relationships in severely burned patients. Surg Forum (1975) 0.81
Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics. Diabetes (1975) 0.81
Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. Diabetes Care (1994) 0.81
Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate. Metabolism (1977) 0.81
Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms. J Clin Endocrinol Metab (2001) 0.81
A clinical algorithm to determine the etiology of brittle diabetes. Diabetes Care (1985) 0.81
The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man. Diabetes (1978) 0.80